Efficacy and Safety of Empagliflozin in Type 1 Diabetes Mellitus Patients: A Systematic Review
(Endocrinol Res Pract 2021; 25: 426-438) DOI: 10.25179/tjem.2021-83912
(Endocrinol Res Pract 2021; 25: 426-438) DOI: 10.25179/tjem.2021-83912
Işılay KALAN SARI, Alev EROĞLU ALTINOVA, Çiğdem ÖZKAN, Müjde AKTÜRK, Ceyla KONCA DEĞERTEKİN, Ethem Turgay CERİT, Mehmet Muhittin YALÇIN, Füsun BALOŞ TÖRÜNER, Ayhan KARAKOÇ, İlhan YETKİN, Göksun AYVAZ, Nuri ÇAKIR
(Endocrinol Res Pract 2020; 24: 109-114) DOI: 10.25179/tjem.2020-74444
Nizameddin KOCA, Metin GÜÇLÜ, İrfan ESEN, Gamze EMLEK, Sinem KIYICI, Gürcan KISAKOL
(Endocrinol Res Pract 2019; 23: 8-18) DOI: 10.25179/tjem.2018-61916